These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study. Racoveanu C, Stanescu DC, Manicatide M, Stroescu V. Bull Physiopathol Respir (Nancy); 1970 Mar; 6(4):809-18. PubMed ID: 4940888 [No Abstract] [Full Text] [Related]
6. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study. Racoveanu C, Stanescu DC, Manicatide M, Stroescu V. Postgrad Med J; 1971 Mar; 47():Suppl:83-6. PubMed ID: 4929399 [No Abstract] [Full Text] [Related]
7. Comparison of orciprenaline, ephedrine and methoxyphenamine as oral bronchodilators. Kerr A, Gebbie T. N Z Med J; 1973 May; 77(492):320-2. PubMed ID: 4578811 [No Abstract] [Full Text] [Related]
15. [Experiences with hexoprenaline in the therapy of bronchial asthma in children]. Stur O. Wien Med Wochenschr; 1970 Sep 26; 120(39):670-1. PubMed ID: 5518011 [No Abstract] [Full Text] [Related]
16. Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Freedman BJ. Br J Dis Chest; 1972 Jul 26; 66(3):222-9. PubMed ID: 4557902 [No Abstract] [Full Text] [Related]
17. [Results of a clinical trial of a newly developped bronchospasmolytic agent (hexoprenalin, Ipradol)]. Witek F. Wien Klin Wochenschr; 1971 Feb 19; 83(7):114-7. PubMed ID: 5278390 [No Abstract] [Full Text] [Related]
19. Double-blind trial of a new bronchodilator in asthmatic children. Olinsky A, Wolfsdorf J. S Afr Med J; 1972 May 13; 46(20):609-10. PubMed ID: 4402655 [No Abstract] [Full Text] [Related]
20. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance. Bäcklund L, Fagerberg E. Scand J Respir Dis; 1968 May 13; 49(4):284-90. PubMed ID: 5194717 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]